Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia
· Delayed Price · Currency is SAR
64.00
-1.00 (-1.54%)
Aug 14, 2025, 3:19 PM AST
TADAWUL:9620 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 19.86 | 18.03 | 17.01 |
| Revenue Growth (YoY) | 10.11% | 6.04% | - |
| Cost of Revenue | 10.47 | 9.87 | 8.7 |
| Gross Profit | 9.38 | 8.17 | 8.31 |
| Selling, General & Admin | 4.69 | 4.15 | 4.68 |
| Other Operating Expenses | - | - | -0.11 |
| Operating Expenses | 4.27 | 3.82 | 4.58 |
| Operating Income | 5.12 | 4.34 | 3.73 |
| Interest Expense | -0.07 | -0.09 | -0.1 |
| Pretax Income | 5.04 | 4.26 | 3.63 |
| Income Tax Expense | 0.26 | 0.1 | 0.12 |
| Net Income | 4.78 | 4.16 | 3.51 |
| Net Income to Common | 4.78 | 4.16 | 3.51 |
| Net Income Growth | 14.85% | 18.47% | - |
| Shares Outstanding (Basic) | 1 | 1 | - |
| Shares Outstanding (Diluted) | 1 | 1 | - |
| Shares Change (YoY) | 38.36% | - | - |
| EPS (Basic) | 4.68 | 5.64 | - |
| EPS (Diluted) | 4.68 | 5.64 | - |
| EPS Growth | -16.99% | - | - |
| Free Cash Flow | 5.27 | -1.74 | 4.53 |
| Free Cash Flow Per Share | 5.16 | -2.36 | - |
| Dividend Per Share | 3.000 | - | - |
| Gross Margin | 47.26% | 45.29% | 48.87% |
| Operating Margin | 25.77% | 24.09% | 21.95% |
| Profit Margin | 24.07% | 23.08% | 20.66% |
| Free Cash Flow Margin | 26.55% | -9.65% | 26.61% |
| EBITDA | 6.05 | 5.17 | 4.63 |
| EBITDA Margin | 30.45% | 28.65% | 27.25% |
| D&A For EBITDA | 0.93 | 0.82 | 0.9 |
| EBIT | 5.12 | 4.34 | 3.73 |
| EBIT Margin | 25.77% | 24.09% | 21.95% |
| Effective Tax Rate | 5.24% | 2.27% | 3.32% |
| Advertising Expenses | 0.43 | 0.36 | 0.17 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.